News

If CVS and Aetna are truly charting the future of healthcare in this country, then it’s long past-time that their actions align to their rhetoric.

The Spiration Valve System treats emphysema by blocking air from entering diseased areas of the lung.

Can we learn from the last flu season and prepare for the coming peak influenza activity of the current season?

Healthcare provider employment opportunies have risen 7.1%—an increase from 2017's reported rate of 5%. Where are the jobs in most demand?

Patients with diabetic macular edema who do not show sufficient progress after anti-VEGF-A treatment may soon have a new option.

The pressure for pharma to exist in a permanent state of innovation gets us better therapeutics, but it’s driving up costs unsustainably.

Ophthotech says it’s sidelining its Zimura/Lucentis program despite positive phase 2a results.

The non-invasive device is now the first and only FDA product approved for the prevention of cluster headache.

In this retrospective study, 18.5% of children became drug-free while on the ketogenic diet.

Successful 8-week treatment of newly diagnosed HCV genotype 1 adds to evidence that early detection could enable shorter, less costly treatments.

A new, large cohort study has confirmed the link between conditions, which was only previously confirmed in adult patients.

The FDA has approved Dextenza, a dexamethasone ophthalmic insert, for the treatment of ocular pain following ophthalmic surgery.

How the opioid epidemic and high drug prices have brought the hepatitis C burden onto a younger population in 2018.

The FDA has accepted a Biologics License Application as well as granted Priority Review for the gene therapy that treats spinal muscular atrophy (SMA) Type 1.

The effects of Charles Bonnet Syndrome have been fairly documented, yet its pathology has been minimally assessed.

Patients frequently report not receiving sufficient information about COPD and how to manage it, investigators noted.

While common in adults, congenital cytomegalovirus may cause problems such as hearing and vision loss in newborns.

HCV RNA in peripheral blood mononuclear cells predicted relapse of HCV genotype 4 in cirrhotic patients who were non-viremic after treatment.

Wiviott, senior investigator of the DECLARE-TIMI 58 trial, says that SGLT2 inhibitors and GLP-1 receptor agonists are changing the paradigm of how clinicians manage diabetes and cardiovascular risk.

New research suggests HCV coinfection is dangerous for pregnant women with HIV.

Investigators test methods of incorporating smaller, localized datasets to improve influenza outbreak forecasts and increase community preparedness.

New trial results show adding ribavirin to a sofosbuvir plus velpatasvir regimen is beneficial for the considered difficult-to-reach patient population.

A recent study disproves a long-held belief that annual flu shots had a negative impact on vaccine effectiveness.

Rapidly accumulating evidence indicates that delayed introduction of allergenic foods may have contributed to the unexplained rise in food allergy rates over the past 20 years.

Outcomes with lacosamide monotherapy for focal seizures in real-world practice were similar to clinical trials but varied with antiepileptic drug history.

The FDA has approved amifampridine (Firdapse) tablets as the first ever treatment of the rare autoimmune disorder, Lambert-Eaton myasthenic syndrome (LEMS) in adults.

The rare disease is associated with other autoimmune conditions including small cell lunger cancer, and is estimated to be prevalent in approximately 3 million people worldwide.

Progestin compound segesterone acetate, which would be combined with testosterone, is currently marketed for the use of hormonal contraception, and for the treatment of endometriosis.